BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37292206)

  • 1. The analysis of cathepsin L that mediates cellular SARS-CoV-2 infection leading to COVID-19 in head and neck squamous cell carcinoma.
    Gao F; Wang X; Qin N; Zhang M; Liao M; Zeng M; Lu D; Sha O
    Front Immunol; 2023; 14():1156038. PubMed ID: 37292206
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COVID-19 receptor and malignant cancers: Association of
    Zhang L; Wei C; Li D; He J; Liu S; Deng H; Cheng J; Du J; Liu X; Chen H; Sun S; Yu H; Fu J
    Int J Biol Sci; 2022; 18(6):2362-2371. PubMed ID: 35414771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic, epigenomic, and immune subtype analysis of CTSL/B and SARS-CoV-2 receptor ACE2 in pan-cancer.
    Li H; Xie L; Chen L; Zhang L; Han Y; Yan Z; Guo X
    Aging (Albany NY); 2020 Nov; 12(22):22370-22389. PubMed ID: 33231569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development.
    Zhao MM; Yang WL; Yang FY; Zhang L; Huang WJ; Hou W; Fan CF; Jin RH; Feng YM; Wang YC; Yang JK
    Signal Transduct Target Ther; 2021 Mar; 6(1):134. PubMed ID: 33774649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pan‑cancer analysis of transmembrane protease serine 2 and cathepsin L that mediate cellular SARS‑CoV‑2 infection leading to COVID-19.
    Katopodis P; Anikin V; Randeva HS; Spandidos DA; Chatha K; Kyrou I; Karteris E
    Int J Oncol; 2020 Aug; 57(2):533-539. PubMed ID: 32468052
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TMPRSS2, a SARS-CoV-2 internalization protease is downregulated in head and neck cancer patients.
    Sacconi A; Donzelli S; Pulito C; Ferrero S; Spinella F; Morrone A; Rigoni M; Pimpinelli F; Ensoli F; Sanguineti G; Pellini R; Agrawal N; Izumchenko E; Ciliberto G; Giannì A; Muti P; Strano S; Blandino G
    J Exp Clin Cancer Res; 2020 Sep; 39(1):200. PubMed ID: 32967703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine disrupts lysosomal gene expression: A hypothesis for COVID19 treatment.
    Smieszek SP; Przychodzen BP; Polymeropoulos MH
    Int J Antimicrob Agents; 2020 Jun; 55(6):106004. PubMed ID: 32361028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel neutrophil extracellular trap signature to predict prognosis and immunotherapy response in head and neck squamous cell carcinoma.
    Li Q; Chen W; Li Q; Mao J; Chen X
    Front Immunol; 2022; 13():1019967. PubMed ID: 36225931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profile of SARS-CoV-2 cellular entry proteins in normal oral mucosa and oral squamous cell carcinoma.
    Sapkota D; Sharma S; Søland TM; Braz-Silva PH; Teh MT
    Clin Exp Dent Res; 2022 Feb; 8(1):117-122. PubMed ID: 34726347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expressions and significances of CTSL, the target of COVID-19 on GBM.
    Dong Q; Li Q; Duan L; Wang H; Yan Y; Yin H; Niu L; Zhang H; Wang B; Yuan G; Pan Y
    J Cancer Res Clin Oncol; 2022 Mar; 148(3):599-608. PubMed ID: 34807310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An ion-channel-gene-based prediction model for head and neck squamous cell carcinoma: Prognostic assessment and treatment guidance.
    Han Y; Shi Y; Chen B; Wang J; Liu Y; Sheng S; Fu Z; Shen C; Wang X; Yin S; Li H
    Front Immunol; 2022; 13():961695. PubMed ID: 36389709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Signature of N
    Chen J; Lu T; Zhong F; Lv Q; Fang M; Tu Z; Ji Y; Li J; Gong X
    Front Immunol; 2022; 13():809872. PubMed ID: 35185897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
    Li Z; Shen L; Li Y; Shen L; Li N
    Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE2C promotes the progression of head and neck squamous cell carcinoma.
    Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression of ACTL8 is poor prognosis and accelerates cell progression in head and neck squamous cell carcinoma.
    Li B; Zhu J; Meng L
    Mol Med Rep; 2019 Feb; 19(2):877-884. PubMed ID: 30535476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology.
    Kumar A; Kumar S; Narayan RK; Kumari C; Pareek V; Prasoon P
    Viral Immunol; 2021 Jun; 34(5):352-357. PubMed ID: 33481684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of immune-related lncRNA panel for predicting immune checkpoint blockade and prognosis in head and neck squamous cell carcinoma.
    Li Q; Shen Z; Shen Y; Deng H; Shen Y; Wang J; Zhan G; Zhou C
    J Clin Lab Anal; 2022 Jun; 36(6):e24484. PubMed ID: 35561269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low expression of TMPRSS2-a SARS-CoV-2 internalization protease-associates with basal subtype of head and neck squamous cell carcinoma.
    Tiwari J; Tripathi N; Srivastava RS; Kumar S; Singh S; Jain S; Khattri A
    Transl Oncol; 2022 Aug; 22():101458. PubMed ID: 35607455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptome analysis reveals the prognostic and immune infiltration characteristics of glycolysis and hypoxia in head and neck squamous cell carcinoma.
    Liu J; Lu J; Li W
    BMC Cancer; 2022 Mar; 22(1):352. PubMed ID: 35361159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.